FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220853464> ?p ?o ?g. }

• W4220853464 endingPage "218" @default.
• W4220853464 startingPage "218" @default.
• W4220853464 abstract "This paper presents an alternative vaccination platform that provides long-term cellular immune protection mediated by cytotoxic T-cells. The immune response via cellular immunity creates superior resistance to viral mutations, which are currently the greatest threat to the global vaccination campaign. Furthermore, we also propose a safer, more facile, and physiologically appropriate immunization method using either intranasal or oral administration. The underlying technology is an adaptation of synthetic long peptides (SLPs) previously used in cancer immunotherapy. The overall quality of the SLP constructs was validated using in silico methods. SLPs comprising HLA class I and class II epitopes were designed to stimulate antigen cross-presentation and canonical class II presentation by dendritic cells. The desired effect is a cytotoxic T cell-mediated prompt and specific immune response against the virus-infected epithelia and a rapid and robust virus clearance. Epitopes isolated from COVID-19 convalescent patients were screened for HLA class I and class II binding (NetMHCpan and NetMHCIIpan) and highest HLA population coverage (IEDB Population Coverage). 15 class I and 4 class II epitopes were identified and used for this SLP design. The constructs were characterized based on their toxicity (ToxinPred), allergenicity (AllerCatPro), immunogenicity (VaxiJen 2.0), and physico-chemical parameters (ProtParam). Based on in silico predictions, out of 60 possible SLPs, 36 candidate structures presented a high probability to be immunogenic, non-allergenic, non-toxic, and stable. 3D peptide folding followed by 3D structure validation (PROCHECK) and molecular docking studies (HADDOCK 2.4) with Toll-like receptors 2 and 4 provided positive results, suggestive for favorable antigen presentation and immune stimulation." @default.
• W4220853464 created "2022-04-03" @default.
• W4220853464 creator A5077498019 @default.
• W4220853464 creator A5078781592 @default.
• W4220853464 date "2022-01-30" @default.
• W4220853464 modified "2023-10-14" @default.
• W4220853464 title "Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach" @default.
• W4220853464 cites W1503364994 @default.
• W4220853464 cites W1948562438 @default.
• W4220853464 cites W1986191025 @default.
• W4220853464 cites W2001482654 @default.
• W4220853464 cites W2014274241 @default.
• W4220853464 cites W2057021995 @default.
• W4220853464 cites W2102367710 @default.
• W4220853464 cites W2115167726 @default.
• W4220853464 cites W2127934565 @default.
• W4220853464 cites W2128013710 @default.
• W4220853464 cites W2135926866 @default.
• W4220853464 cites W2153983456 @default.
• W4220853464 cites W2154019529 @default.
• W4220853464 cites W2225235469 @default.
• W4220853464 cites W2292472819 @default.
• W4220853464 cites W2336749655 @default.
• W4220853464 cites W2512372054 @default.
• W4220853464 cites W2538176089 @default.
• W4220853464 cites W2585550611 @default.
• W4220853464 cites W2782788794 @default.
• W4220853464 cites W2909455948 @default.
• W4220853464 cites W2910081451 @default.
• W4220853464 cites W2912205029 @default.
• W4220853464 cites W2914962392 @default.
• W4220853464 cites W2920668714 @default.
• W4220853464 cites W2972594981 @default.
• W4220853464 cites W2995175706 @default.
• W4220853464 cites W3006323153 @default.
• W4220853464 cites W3024020200 @default.
• W4220853464 cites W3024570138 @default.
• W4220853464 cites W3024625724 @default.
• W4220853464 cites W3027458630 @default.
• W4220853464 cites W3036290265 @default.
• W4220853464 cites W3041689372 @default.
• W4220853464 cites W3042183476 @default.
• W4220853464 cites W3048775784 @default.
• W4220853464 cites W3132204309 @default.
• W4220853464 cites W3157024165 @default.
• W4220853464 cites W3164848793 @default.
• W4220853464 cites W3178825223 @default.
• W4220853464 cites W3179076372 @default.
• W4220853464 cites W3212423563 @default.
• W4220853464 cites W3214271933 @default.
• W4220853464 cites W4200229269 @default.
• W4220853464 cites W4200560336 @default.
• W4220853464 cites W4243141279 @default.
• W4220853464 doi "https://doi.org/10.3390/vaccines10020218" @default.
• W4220853464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35214676" @default.
• W4220853464 hasPublicationYear "2022" @default.
• W4220853464 type Work @default.
• W4220853464 citedByCount "2" @default.
• W4220853464 countsByYear W42208534642023 @default.
• W4220853464 crossrefType "journal-article" @default.
• W4220853464 hasAuthorship W4220853464A5077498019 @default.
• W4220853464 hasAuthorship W4220853464A5078781592 @default.
• W4220853464 hasBestOaLocation W42208534641 @default.
• W4220853464 hasConcept C147483822 @default.
• W4220853464 hasConcept C154317977 @default.
• W4220853464 hasConcept C159047783 @default.
• W4220853464 hasConcept C170627219 @default.
• W4220853464 hasConcept C188280979 @default.
• W4220853464 hasConcept C195616568 @default.
• W4220853464 hasConcept C202751555 @default.
• W4220853464 hasConcept C203014093 @default.
• W4220853464 hasConcept C207936829 @default.
• W4220853464 hasConcept C2776090121 @default.
• W4220853464 hasConcept C2780868878 @default.
• W4220853464 hasConcept C2908647359 @default.
• W4220853464 hasConcept C54355233 @default.
• W4220853464 hasConcept C71924100 @default.
• W4220853464 hasConcept C83464605 @default.
• W4220853464 hasConcept C86803240 @default.
• W4220853464 hasConcept C8891405 @default.
• W4220853464 hasConcept C99454951 @default.
• W4220853464 hasConceptScore W4220853464C147483822 @default.
• W4220853464 hasConceptScore W4220853464C154317977 @default.
• W4220853464 hasConceptScore W4220853464C159047783 @default.
• W4220853464 hasConceptScore W4220853464C170627219 @default.
• W4220853464 hasConceptScore W4220853464C188280979 @default.
• W4220853464 hasConceptScore W4220853464C195616568 @default.
• W4220853464 hasConceptScore W4220853464C202751555 @default.
• W4220853464 hasConceptScore W4220853464C203014093 @default.
• W4220853464 hasConceptScore W4220853464C207936829 @default.
• W4220853464 hasConceptScore W4220853464C2776090121 @default.
• W4220853464 hasConceptScore W4220853464C2780868878 @default.
• W4220853464 hasConceptScore W4220853464C2908647359 @default.
• W4220853464 hasConceptScore W4220853464C54355233 @default.
• W4220853464 hasConceptScore W4220853464C71924100 @default.
• W4220853464 hasConceptScore W4220853464C83464605 @default.
• W4220853464 hasConceptScore W4220853464C86803240 @default.
• W4220853464 hasConceptScore W4220853464C8891405 @default.

• next